Maximizing insights from nonclinical safety studies in the context of rising costs and changing regulations
{{output}}
The traditional paradigm of non-rodent safety assessment studies, primarily reliant on non-human primates (NHPs) and dogs, is undergoing a transformation. During the 2023 Safety Pharmacology Society Annual Meeting, scientists from leading nonclinical contract ... ...
